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Definition A genetic disorder that is characterized by an aged
appearance at birth (progeria), with growth delays before and after
birth, and a deficiency or absence in a layer of fat below the skin.
Diagnosis

In most patients, WRS is diagnosed shortly after
birth, based upon thorough clinical evaluation and identification of
characteristic physical findings such as: short stature, characteristic
craniofacial and skeletal malformations, and absence or deficiency of
subcutaneous fat. In some cases, specialized tests may also be
conducted to detect abnormalities of cranial bones. In addition, it is
possible that CAT, MRI, and/or other specialized tests may reveal
widespread loss of myelin sheath within the white matter of the brain
(pure sudanophilic leukodystrophy) or other abnormalities as
described above.

Abstract Wiedemann-Rautenstrauch syndrome is a type of progeria, characterized by premature aging. Wiedemann-Rautenstrauch
syndrome is a rare disorder with only three dozen cases since its first diagnosis in 1979. The syndrome is the result of a mutation within
POLR3A gene that is responsible for the coding of the large subunit of RNA polymerase III. Mutation to this gene leads to the production
of abnormal proteins systems resulting in a faulty RNA polymerase III. The condition itself displays as an inherited autosomal recessive
pattern, indicating that both copies of the gene in each cell are affected. Current treatment is directed toward the specific symptoms that are
apparent in each individual We will present the molecular mechanism and developmental progression of Wiedemann-Rautenstrauch
syndrome as well as potential therapeutic targets for treatment.
Clinical Description People who have this syndrome:
●

●

Do not grow or gain weight at an expected rate
● Facial features that make them
appear older (larger head, triangular
face with prominent forehead, pointed
chin, lower set ears, lower eyelids)
● Translucent skin with no fat
underneath it
● Little to no hair on their head

Etiology The syndrome is caused by a mutation in
a gene known as POLR3A. When this gene is not
mutated it works to provide instructions for making the
largest subunit of RNA polymerase III. The mutation
causes abnormal formation of the large subunit which
ultimately leads to the impaired ability to synthesize
RNA. This condition is inherited in an autosomal
recessive pattern.

Management The treatment of this syndrome is generally directed
towards specific symptoms that the individual is experiencing. There is
not a treatment that will cure the syndrome instead they are supportive and
symptomatic. This will usually be carried out by a team of specialists
including, but not limited:
●
Physical therapist
●
Neurologist
●
Genetic counselor
●
Physician

Antenatal diagnosis In some cases, growth disability,
macrocephaly and/or other characteristic findings of WRS may be
detected prenatally by ultrasound.

Prognosis This is a rare genetic disorder that leads to a decreased life expectancy in affected individuals. The life expectancy and
severity of this syndrome both vary from case to case. There are some children who live into their teens or twenties but this is not common.

Epidemiology WRS is an extremely rare disease that
appears to affect males and females equally. WRS has been
observed in various ethnic and racial groups. The disorder was
initially described as a distinct entity in 1979 (Wiedemann HR)
based upon observation of two unrelated individuals as well as
previous reports of two affected sisters in 1977 (Rautenstrauch T).
More that 35 affected individuals have been reported in the medical
literature to date.

Differential Diagnosis Hutchinson-Gilford progeria
syndrome, De Barsy syndrome, Hallerman-Streiff syndrome,
Cockayne syndrome
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